conditions leukoplakia

REC109add9e521810

Leukoplakia

Condition:Leukoplakia
Other:Leukoplasia, leukokeratosis, idiopathic keratosis
ICD-10 Codes:K13.2, N48.0, N88.0, N89.4, N90.4

Naturopathic Treatments

Lifestyle
• avoid or discontinue alcohol or tobacco use

Diet
• increase fruits and vegetables

Supplements
vitamin A
• beta-carotene
lycopene
• fiber

Other
• photodynamic therapy

Conventional Treatments

• surgical excision
• cryotherapy ablation
• carbon dioxide laser ablation
• discontinue alcohol and tobacco use

Signs & Symptoms

• white, gray, fuzzy patches on tongue, mouth or inside of cheeks
• cannot be scraped off or wiped away
• thickened in areas
• irregular in shape
• may also have reddish, red precancerous lesions

DDx

• oral candidiasis
• oral hairy leukoplakia
• geographic tongue (benign migratory glossitis)
• hairy tongue (hyperplastic papillae)
• lichen planus
• squamous cell carcinoma

Pathogenesis

• idiopathic etiology
• risk factors
- alcohol consumption
- tobacco use
- betel nut chewing
- irritation (rough teeth, dentures and crowns)
- vitamin deficiency
- candidiasis
- Epstein-Barr virus infection
- HIV infection

Diagnostics

• biopsy

References

"Show references"

"Hide references"

Rai B, Kaur J, Jacobs R, Singh J. Possible action mechanism for curcumin in
pre-cancerous lesions based on serum and salivary markers of oxidative stress. J
Oral Sci. 2010 Jun;52(2):251-6. PubMed PMID: 20587949.

Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR,
Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH,
Wang YJ, Tsai CC, Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive
agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001
Jul-Aug;21(4B):2895-900. PubMed PMID: 11712783.

Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating
oral leukoplakia. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001829. Review.
PubMed PMID: 17054142.

Gupta PC, Hebert JR, Bhonsle RB, Sinor PN, Mehta H, Mehta FS. Dietary factors
in oral leukoplakia and submucous fibrosis in a population-based case control
study in Gujarat, India. Oral Dis. 1998 Sep;4(3):200-6. PubMed PMID: 9972171.

Winn DM. Diet and nutrition in the etiology of oral cancer. Am J Clin Nutr.
1995 Feb;61(2):437S-445S. Review. PubMed PMID: 7840089.

Kaugars GE, Silverman S Jr, Lovas JG, Brandt RB, Riley WT, Dao Q, Singh VN,
Gallo J. A clinical trial of antioxidant supplements in the treatment of oral
leukoplakia. Oral Surg Oral Med Oral Pathol. 1994 Oct;78(4):462-8. PubMed PMID:
7800378.

Garewal H. Chemoprevention of oral cancer: beta-carotene and vitamin E in
leukoplakia. Eur J Cancer Prev. 1994 Mar;3(2):101-7. Review. PubMed PMID:
8019381.

Bose SC, Singh M, Vyas P, Singh M. Plasma zinc antioxidant vitamins,
glutathione levels and total antioxidant activity in oral leukoplakia. Dent Res J
(Isfahan). 2012 Mar;9(2):158-61. PubMed PMID: 22623931; PubMed Central PMCID:
PMC3353691.

Lu R, Dan H, Wu R, Meng W, Liu N, Jin X, Zhou M, Zeng X, Zhou G, Chen Q.
Lycopene: features and potential significance in the oral cancer and precancerous
lesions. J Oral Pathol Med. 2011 May;40(5):361-8. doi:
10.1111/j.1600-0714.2010.00991.x. Epub 2010 Dec 30. Review. PubMed PMID:
21198870.

Ribeiro AS, Salles PR, da Silva TA, Mesquita RA. A review of the nonsurgical
treatment of oral leukoplakia. Int J Dent. 2010;2010:186018. doi:
10.1155/2010/186018. Epub 2010 Feb 23. PubMed PMID: 20339486; PubMed Central
PMCID: PMC2836849.

Almadori G, Bussu F, Navarra P, Galli J, Paludetti G, Giardina B, Maurizi M.
Pilot phase IIA study for evaluation of the efficacy of folic acid in the
treatment of laryngeal leucoplakia. Cancer. 2006 Jul 15;107(2):328-36. PubMed
PMID: 16770770.

Almadori G, Bussu F, Galli J, Cadoni G, Zappacosta B, Persichilli S, Minucci
A, Giardina B, Maurizi M. Serum levels of folate, homocysteine, and vitamin B12
in head and neck squamous cell carcinoma and in laryngeal leukoplakia. Cancer.
2005 Jan 15;103(2):284-92. PubMed PMID: 15593092.

Singh M, Krishanappa R, Bagewadi A, Keluskar V. Efficacy of oral lycopene in
the treatment of oral leukoplakia. Oral Oncol. 2004 Jul;40(6):591-6. PubMed PMID:
15063387.

Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Systematic review of
randomized trials for the treatment of oral leukoplakia. J Dent Educ. 2002
Aug;66(8):896-902. Review. PubMed PMID: 12214837.

Nagao T, Ikeda N, Warnakulasuriya S, Fukano H, Yuasa H, Yano M, Miyazaki H,
Ito Y. Serum antioxidant micronutrients and the risk of oral leukoplakia among
Japanese. Oral Oncol. 2000 Sep;36(5):466-70. PubMed PMID: 10964055.

Epstein JB, Gorsky M. Topical application of vitamin A to oral leukoplakia: A
clinical case series. Cancer. 1999 Sep 15;86(6):921-7. PubMed PMID: 10491516.

Cianfriglia F, Manieri A, Di Gregorio DA, Di Iorio AM. Retinol dietary intake
and oral leukoplakia development. J Exp Clin Cancer Res. 1998 Sep;17(3):331-6.
PubMed PMID: 9894771.

Liede KE, Alfthan G, Hietanen JH, Haukka JK, Saxen LM, Heinonen OP.
Beta-carotene concentration in buccal mucosal cells with and without dysplastic
oral leukoplakia after long-term beta-carotene supplementation in male smokers.
Eur J Clin Nutr. 1998 Dec;52(12):872-6. PubMed PMID: 9881881.

Sankaranarayanan R, Mathew B, Varghese C, Sudhakaran PR, Menon V, Jayadeep A,
Nair MK, Mathews C, Mahalingam TR, Balaram P, Nair PP. Chemoprevention of oral
leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol. 1997
Jul;33(4):231-6. PubMed PMID: 9307711.

Barth TJ, ZÖller J, KÜbler A, Born IA, Osswald H. Redifferentiation of oral
dysplastic mucosa by the application of the antioxidants beta-carotene,
alpha-tocopherol and vitamin C. Int J Vitam Nutr Res. 1997;67(5):368-76. PubMed
PMID: 9350480.

Benner SE, Wargovich MJ, Lippman SM, Fisher R, Velasco M, Winn RJ, Hong WK.
Reduction in oral mucosa micronuclei frequency following alpha-tocopherol
treatment of oral leukoplakia. Cancer Epidemiol Biomarkers Prev. 1994
Jan-Feb;3(1):73-6. PubMed PMID: 8118389.

Benner SE, Winn RJ, Lippman SM, Poland J, Hansen KS, Luna MA, Hong WK.
Regression of oral leukoplakia with alpha-tocopherol: a community clinical
oncology program chemoprevention study. J Natl Cancer Inst. 1993 Jan
6;85(1):44-7. PubMed PMID: 8416256.

Toma S, Benso S, Albanese E, Palumbo R, Cantoni E, NicolÒ G, Mangiante P.
Treatment of oral leukoplakia with beta-carotene. Oncology. 1992;49(2):77-81.
PubMed PMID: 1574255.

Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.healthydigestionclinic.com © 2015 NDAssist Inc. and/or its affiliates. All rights reserved.